Rubius Therapeutics, Inc. Gains 48.58%

Thu, Sep 08, 2022 at 07:25 PM
Rubius Therapeutics, Inc. Gains 48.58%

Rubius Therapeutics, Inc. (RUBY:NASDAQ) rocketted at $1.29, representing a gain of 48.6%. On Thu, Sep 08, 2022, RUBY:NASDAQ touched a New 2-Week High of $1.29. From Thu, Aug 25, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.